News
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood 1997; 89: 3345–3353.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback